NYSE:HCA - HCA Healthcare Stock Price, Price Target & More

Get Started

$103.69 +0.09 (+0.09 %)

(As of 05/25/2018 04:00 PM ET)

Previous Close$103.69

Today's Range$103.42 - $104.09

52-Week Range$71.18 - $106.84

Volume1.17 million shs

Average Volume1.96 million shs

Market Capitalization$36.19 billion

P/E Ratio15.73

Dividend Yield1.35%

Beta0.48

About HCA Healthcare (NYSE:HCA)

HCA Healthcare, Inc., through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services. It also operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, and adolescent and adult alcohol and drug abuse treatment and counseling. In addition, the company operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. As of February 12, 2018, it owned and operated 179 hospitals and 120 freestanding surgery centers, and various other healthcare facilities in 20 states and the United Kingdom. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

Receive HCA News and Ratings via Email

Sign-up to receive the latest news and ratings for HCA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry General medical & surgical hospitals

Sub-IndustryHealth Care Facilities

SectorMedical

SymbolNYSE:HCA

CUSIP40412C10

Webwww.hcahealthcare.com

Phone615-344-9551

Debt

Debt-to-Equity Ratio-7.13

Current Ratio1.39

Quick Ratio1.17

Price-To-Earnings

Trailing P/E Ratio15.73

Forward P/E Ratio11.74

P/E Growth1.01

Sales & Book Value

Annual Sales$47.65 billion

Price / Sales0.76

Cash Flow$13.0428 per share

Price / Cash7.95

Book Value($12.69) per share

Price / Book-8.17

Profitability

EPS (Most Recent Fiscal Year)$6.59

Net Income$2.22 billion

Net Margins5.96%

Return on Equity-55.50%

Return on Assets7.53%

Miscellaneous

Employees253,000

Outstanding Shares349,300,000

HCA Healthcare (NYSE:HCA) Frequently Asked Questions

What is HCA Healthcare's stock symbol?

HCA Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "HCA."

How often does HCA Healthcare pay dividends? What is the dividend yield for HCA Healthcare?

HCA Healthcare declared a quarterly dividend on Tuesday, May 1st. Stockholders of record on Friday, June 1st will be paid a dividend of $0.35 per share on Friday, June 29th. This represents a $1.40 annualized dividend and a dividend yield of 1.35%. The ex-dividend date is Thursday, May 31st. View HCA Healthcare's Dividend History.

How were HCA Healthcare's earnings last quarter?

HCA Healthcare Inc (NYSE:HCA) issued its quarterly earnings results on Tuesday, May, 1st. The company reported $2.33 EPS for the quarter, topping the consensus estimate of $2.07 by $0.26. The firm had revenue of $11.42 billion for the quarter, compared to the consensus estimate of $11.29 billion. HCA Healthcare had a net margin of 5.96% and a negative return on equity of 55.50%. The company's revenue for the quarter was up 7.5% compared to the same quarter last year. During the same quarter last year, the firm posted $1.74 EPS. View HCA Healthcare's Earnings History.

When is HCA Healthcare's next earnings date?

HCA Healthcare is scheduled to release their next quarterly earnings announcement on Monday, July, 23rd 2018. View Earnings Estimates for HCA Healthcare.

What guidance has HCA Healthcare issued on next quarter's earnings?

HCA Healthcare issued an update on its FY18 earnings guidance on Tuesday, May, 1st. The company provided earnings per share (EPS) guidance of $8.50-9.00 for the period, compared to the Thomson Reuters consensus EPS estimate of $8.69. The company issued revenue guidance of $45-46 billion, compared to the consensus revenue estimate of $45.67 billion.

What price target have analysts set for HCA?

23 brokers have issued 12-month price objectives for HCA Healthcare's stock. Their predictions range from $81.00 to $122.00. On average, they anticipate HCA Healthcare's stock price to reach $105.8333 in the next year. View Analyst Ratings for HCA Healthcare.

What are Wall Street analysts saying about HCA Healthcare stock?

Here are some recent quotes from research analysts about HCA Healthcare stock:

1. According to Zacks Investment Research, "HCA Healthcare’s continues to suffer from weak commercial business that has faced declining volumes of admissions over the last few quarters. High level of bad debts and disappointing international business are other headwinds. The company is expected to report first quarter results in May first week. An unfavorable Zacks Rank #4 and an Earnings ESP of -2.40% makes earnings surprise prediction difficult. Nonetheless, HCA Healthcare’s shares have outperformed the industry in a year’s time. Its top line has been growing over the past several quarters on strong volumes and improved payor and service mix. A number of acquisitions have helped the company gain a strong foothold in the industry." (4/17/2018)
2. Cantor Fitzgerald analysts commented, "HCA reported 4Q17 results that were better than anticipated, although adjusted EPS was impacted by a non-cash increase in the company’s provision for income taxes related to TCJA. Shares are up 5% in early trading." (1/30/2018)

Who are some of HCA Healthcare's key competitors?

Some companies that are related to HCA Healthcare include Universal Health Services (UHS), Tenet Healthcare (THC), LifePoint Health (LPNT), Surgery Partners (SGRY), Community Health Systems (CYH) and Quorum Health (QHC).

Who are HCA Healthcare's key executives?

HCA Healthcare's management team includes the folowing people:

Mr. R. Milton Johnson, Chairman & CEO (Age 61)
Mr. Samuel N. Hazen, Pres & COO (Age 58)
Mr. William B. Rutherford, Exec. VP & CFO (Age 54)
Dr. Jonathan B. Perlin, Pres of Clinical Services & Chief Medical Officer (Age 57)
Mr. Charles J. Hall, Pres of National Group (Age 65)

Has HCA Healthcare been receiving favorable news coverage?

Headlines about HCA stock have been trending somewhat positive recently, Accern Sentiment reports. The research firm ranks the sentiment of media coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. HCA Healthcare earned a news sentiment score of 0.09 on Accern's scale. They also gave media headlines about the company an impact score of 47.30 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the near future.

Who are HCA Healthcare's major shareholders?

HCA Healthcare's stock is owned by a number of of institutional and retail investors. Top institutional investors include Principal Financial Group Inc. (0.12%), Summit Trail Advisors LLC (0.03%), Knightsbridge Asset Management LLC (0.03%), Redwood Investments LLC (0.02%), Amalgamated Bank (0.01%) and Suntrust Banks Inc. (0.01%). Company insiders that own HCA Healthcare stock include A Bruce Moore Jr, Bill B Rutherford, Charles J Hall, Christopher F Wyatt, Jana Joustra Davis, Jane D Englebright, John M Steele, Jonathan B Perlin, Joseph A Sowell III, Michael S Cuffe, P Martin Paslick, Ravi S Chari, Robert A Waterman, Samuel N Hazen, Sandra L Morgan, Thomas F Frist Jr and Victor L Campbell. View Institutional Ownership Trends for HCA Healthcare.

Which institutional investors are selling HCA Healthcare stock?

HCA stock was sold by a variety of institutional investors in the last quarter, including Centaurus Financial Inc., Redwood Investments LLC, Principal Financial Group Inc. and Amalgamated Bank. Company insiders that have sold HCA Healthcare company stock in the last year include Bill B Rutherford, Charles J Hall, Jonathan B Perlin, Joseph A Sowell III, Michael S Cuffe, Ravi S Chari, Samuel N Hazen, Sandra L Morgan and Victor L Campbell. View Insider Buying and Selling for HCA Healthcare.

Which institutional investors are buying HCA Healthcare stock?

HCA stock was bought by a variety of institutional investors in the last quarter, including Summit Trail Advisors LLC, Knightsbridge Asset Management LLC, Suntrust Banks Inc., WINTON GROUP Ltd and Howard Capital Management Inc.. View Insider Buying and Selling for HCA Healthcare.

How do I buy shares of HCA Healthcare?

Shares of HCA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is HCA Healthcare's stock price today?

One share of HCA stock can currently be purchased for approximately $103.69.

How big of a company is HCA Healthcare?

HCA Healthcare has a market capitalization of $36.19 billion and generates $47.65 billion in revenue each year. The company earns $2.22 billion in net income (profit) each year or $6.59 on an earnings per share basis. HCA Healthcare employs 253,000 workers across the globe.

How can I contact HCA Healthcare?

HCA Healthcare's mailing address is ONE PARK PLAZA, NASHVILLE TN, 37203. The company can be reached via phone at 615-344-9551 or via email at [email protected]

MarketBeat Community Rating for HCA Healthcare (HCA)

Community Ranking:		3.6 out of 5 ( )
Outperform Votes:		804 (Vote Outperform)
Underperform Votes:		322 (Vote Underperform)
Total Votes:		1,126

MarketBeat's community ratings are surveys of what our community members think about HCA Healthcare and other stocks. Vote "Outperform" if you believe HCA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HCA will underperform the S&P 500 over the long term. You may vote once every thirty days.

HCA Healthcare (NYSE:HCA) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

23 Wall Street analysts have issued ratings and price targets for HCA Healthcare in the last 12 months. Their average twelve-month price target is $105.8333, suggesting that the stock has a possible upside of 2.07%. The high price target for HCA is $122.00 and the low price target for HCA is $81.00. There are currently 2 sell ratings, 6 hold ratings and 15 buy ratings for the stock, resulting in a consensus rating of "Buy."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Buy	Buy	Buy	Buy
Consensus Rating Score:	2.57	2.57	2.58	2.73
Ratings Breakdown:	2 Sell Rating(s) 6 Hold Rating(s) 15 Buy Rating(s) 0 Strong Buy Rating(s)	2 Sell Rating(s) 6 Hold Rating(s) 15 Buy Rating(s) 0 Strong Buy Rating(s)	2 Sell Rating(s) 6 Hold Rating(s) 16 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 6 Hold Rating(s) 16 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$105.8333	$105.8333	$104.0526	$89.8421
Price Target Upside:	2.07% upside	6.06% upside	6.35% upside	18.38% upside

HCA Healthcare (NYSE:HCA) Consensus Price Target History

Price Target History for HCA Healthcare (NYSE:HCA)

HCA Healthcare (NYSE:HCA) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
3/23/2018	Mizuho	Initiated Coverage	Buy	$115.00	Medium
2/12/2018	Argus	Boost Price Target	Positive ➝ Buy	$9.26 ➝ $114.00	Low
2/1/2018	Sanford C. Bernstein	Reiterated Rating	Market Perform	$105.00 ➝ $116.00	Low
2/1/2018	BMO Capital Markets	Boost Price Target	Outperform ➝ Outperform	$96.00 ➝ $115.00	Low
2/1/2018	Morgan Stanley	Boost Price Target	Underweight ➝ Underweight	$84.00 ➝ $91.00	Low
1/31/2018	Royal Bank of Canada	Boost Price Target	Outperform	$117.00	Low
1/31/2018	Credit Suisse Group	Boost Price Target	Outperform ➝ Outperform	$115.00 ➝ $122.00	Low
1/31/2018	Leerink Swann	Boost Price Target	Outperform ➝ Outperform	$105.00 ➝ $120.00	Low
1/31/2018	SunTrust Banks	Boost Price Target	Buy ➝ Positive	$120.00	Low
1/30/2018	Piper Jaffray Companies	Reiterated Rating	Hold	$101.00	Low
1/30/2018	Cantor Fitzgerald	Reiterated Rating	Buy	$115.00	High
1/30/2018	Wells Fargo & Co	Initiated Coverage	Outperform ➝ Outperform	$116.00	High
1/24/2018	William Blair	Reiterated Rating	Hold		Medium
1/12/2018	Robert W. Baird	Set Price Target	Buy	$104.00	Medium
1/4/2018	Bank of America	Downgrade	Neutral ➝ Underperform	$94.00 ➝ $90.00	Medium
1/3/2018	Goldman Sachs Group	Initiated Coverage	Neutral ➝ Neutral		High
12/12/2017	Citigroup	Upgrade	Neutral ➝ Buy		Medium
11/30/2017	JPMorgan Chase & Co.	Upgrade	Neutral ➝ Overweight		High
11/1/2017	Jefferies Group	Lower Price Target	Buy	$90.00 ➝ $88.00	N/A
10/19/2017	Oppenheimer	Reiterated Rating	Buy	$95.00 ➝ $90.00	N/A
10/19/2017	KeyCorp	Reiterated Rating	Overweight	$95.00 ➝ $90.00	N/A
10/18/2017	Raymond James	Downgrade	Strong-Buy ➝ Market Perform		N/A
10/18/2017	UBS	Downgrade	Outperform ➝ Market Perform		N/A
4/4/2017	Deutsche Bank	Initiated Coverage	Buy	$103.00	Low
1/31/2017	Evercore ISI	Boost Price Target	Buy	$88.00	N/A
1/17/2017	Avondale Partners	Upgrade	Market Perform ➝ Outperform	$96.00	N/A
10/25/2016	Wolfe Research	Initiated Coverage	Outperform		N/A
6/1/2016	Longbow Research	Downgrade	Outperform ➝ Market Perform	$74.00	N/A
6/1/2016	Barclays	Lower Price Target	Overweight	$80.00 ➝ $79.00	N/A

(Data available from 5/26/2016 forward)

HCA Healthcare (NYSE:HCA) Earnings History and Estimates Chart

Earnings by Quarter for HCA Healthcare (NYSE:HCA)

HCA Healthcare (NYSE:HCA) Earnings Estimates

2018 EPS Consensus Estimate: $8.62
2019 EPS Consensus Estimate: $9.51

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	5	$1.97	$2.21	$2.09
Q2 2018	6	$2.05	$2.21	$2.14
Q3 2018	6	$1.68	$1.90	$1.83
Q4 2018	6	$2.47	$2.65	$2.56
Q1 2019	4	$2.14	$2.38	$2.25
Q2 2019	4	$2.38	$2.45	$2.41
Q3 2019	4	$1.87	$2.08	$2.01
Q4 2019	4	$2.67	$2.99	$2.84

HCA Healthcare (NYSE HCA) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
7/23/2018		$2.16					N/A
5/1/2018	Q1 2018	$2.07	$2.33	$11.2890 billion	$11.4230 billion	View	N/A
1/30/2018	Q4 2017	$1.87	$2.12	$11.1925 billion	$11.5620 billion	View	Listen
10/31/2017	Q3 2017	$1.21	$1.21	$10.6959 billion	$10.6960 billion	View	N/A
7/25/2017	Q2 2017	$1.80	$1.75	$10.7573 billion	$10.7330 billion	View	N/A
5/2/2017	Q1 2017	$1.74	$1.74	$10.6447 billion	$10.6230 billion	View	Listen
1/31/2017	Q416	$1.78	$1.89	$10.67 billion	$10.6410 billion	View	N/A
10/27/2016	Q316	$1.42	$1.61	$10.41 billion	$10.27 billion	View	Listen
7/28/2016	Q216	$1.56	$1.66	$10.49 billion	$10.3190 billion	View	Listen
5/3/2016	Q116	$1.49	$1.71	$10.24 billion	$10.26 billion	View	N/A
1/28/2016	Q415	$1.40	$1.69	$10.16 billion	$10.25 billion	View	Listen
10/27/2015	Q315	$1.19	$1.17	$9.90 billion	$9.86 billion	View	Listen
8/5/2015	Q215	$1.34	$1.37	$9.82 billion	$9.8970 billion	View	N/A
5/5/2015	Q115	$1.34	$1.35	$9.56 billion	$9.6760 billion	View	N/A
2/3/2015	Q414	$1.25	$1.33	$9.59 billion	$9.6360 billion	View	N/A
10/28/2014	Q314	$1.05	$1.16	$9.12 billion	$9.22 billion	View	N/A
7/29/2014	Q214	$1.37	$1.37	$8.98 billion	$9.9580 billion	View	N/A
4/29/2014	Q114	$0.85	$0.84	$8.90 billion	$9.6830 billion	View	N/A
2/4/2014	Q114	$0.86	$0.92	$8.82 billion	$8.43 billion	View	N/A
11/5/2013	Q313	$0.74	$0.79	$8.40 billion	$9.4110 billion	View	N/A
8/1/2013	Q2 2013	$0.83	$0.91	$8.44 billion	$8.45 billion	View	Listen
5/2/2013	Q1 2013	$0.82	$0.79	$9.3843 billion	$8.44 billion	View	N/A
2/5/2013	Q4 2012	$0.83	$0.92	$8.95 billion	$8.43 billion	View	N/A
11/1/2012	Q312	$0.90	$0.78	$8.04 billion	$8.06 billion	View	N/A
8/6/2012		$0.78	$0.85			View	N/A
5/3/2012		$0.99	$1.18			View	N/A
2/6/2012		$0.76	$0.94			View	N/A
11/1/2011		$0.43	$0.60			View	N/A
7/25/2011		$0.59	$0.55			View	N/A
5/4/2011		$0.75	$0.85			View	N/A

(Earnings results data provided by Zacks Investment Research)

HCA Healthcare (NYSE:HCA) Dividend Information

HCA Healthcare pays an annual dividend of $1.40 per share, with a dividend yield of 1.35%. HCA's next quarterly dividend payment will be made on Friday, June 29. HCA Healthcare pays out 21.24% of its earnings out as a dividend.

Next Dividend:	6/29/2018
Annual Dividend:	$1.40
Dividend Yield:	1.35%
Dividend Growth:	0.00% (3 Year Average)
Payout Ratio(s):	21.24% (Trailing 12 Months of Earnings) 15.86% (Based on This Year's Estimates) 14.78% (Based on Next Year's Estimates) 10.73% (Based on Cash Flow)

Dividend Payments by Quarter for HCA Healthcare (NYSE:HCA)

HCA Healthcare (NYSE:HCA) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/1/2018	Quarterly	$0.35	1.42%	5/31/2018	6/1/2018	6/29/2018
1/31/2018	quarterly	$0.35	1.38%	2/28/2018	3/1/2018	3/30/2018
12/6/2012	special	$2.00		12/13/2012	12/17/2012	12/21/2012

(Data available from 1/1/2013 forward)

HCA Healthcare (NYSE HCA) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 2.80%
Institutional Ownership Percentage: 70.96%

Insider Trading History for HCA Healthcare (NYSE:HCA)

HCA Healthcare (NYSE HCA) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/17/2018	Jonathan B. Perlin	Insider	Sell	11,520	$104.00	$1,198,080.00
2/21/2018	Charles J Hall	Insider	Sell	49,882	$101.29	$5,052,547.78	62,048
2/20/2018	Thomas F Frist Jr	Major Shareholder	Buy	28,650	$101.07	$2,895,655.50	389,855
2/16/2018	Jonathan B Perlin	CMO	Sell	38,480	$102.05	$3,926,884.00	119,778
2/14/2018	Charles J Hall	Insider	Sell	119,637	$100.14	$11,980,449.18	161,181
2/9/2018	Michael S Cuffe	Insider	Sell	8,335	$97.26	$810,662.10	26,089
2/6/2018	Sandra L Morgan	SVP	Sell	3,698	$96.91	$358,373.18	5,410
2/2/2018	Ravi S. Chari	SVP	Sell	16,270	$101.73	$1,655,147.10
2/1/2018	Bill B Rutherford	CFO	Sell	48,462	$102.42	$4,963,478.04	41,269
2/1/2018	Charles J Hall	Insider	Sell	35,949	$103.09	$3,705,982.41	111,237
1/31/2018	Jonathan B Perlin	CMO	Sell	23,005	$101.55	$2,336,157.75	76,713
1/31/2018	Samuel N Hazen	COO	Sell	56,000	$100.47	$5,626,320.00	136,017
1/30/2018	Joseph A Sowell III	SVP	Sell	22,025	$101.86	$2,243,466.50	27,411
1/26/2018	Joseph A Sowell III	SVP	Sell	58,175	$95.00	$5,526,625.00	40,536
12/15/2017	Michael S. Cuffe	Insider	Sell	2,400	$86.63	$207,912.00
11/22/2017	Michael S Cuffe	Insider	Sell	2,150	$78.00	$167,700.00	12,476
11/16/2017	Victor L Campbell	SVP	Sell	8,000	$75.82	$606,560.00	127,275
11/8/2017	Victor L Campbell	SVP	Sell	8,000	$78.00	$624,000.00	127,275
10/17/2017	Michael S Cuffe	Insider	Sell	2,150	$78.00	$167,700.00	12,476
9/15/2017	Michael S. Cuffe	Insider	Sell	2,150	$79.87	$171,720.50
8/15/2017	Michael S Cuffe	Insider	Sell	2,150	$79.88	$171,742.00	12,363
7/17/2017	Michael S Cuffe	Insider	Sell	2,150	$86.44	$185,846.00	12,363
6/22/2017	Jonathan B. Perlin	Insider	Sell	71,063	$86.00	$6,111,418.00
6/15/2017	Michael S. Cuffe	Insider	Sell	2,150	$84.86	$182,449.00
5/23/2017	Jana Joustra Davis	SVP	Sell	54,689	$82.35	$4,503,639.15	107,892
5/17/2017	Sandra L Morgan	SVP	Sell	5,915	$82.74	$489,407.10	2,420
5/15/2017	Michael S Cuffe	Insider	Sell	2,150	$84.52	$181,718.00	12,254
5/11/2017	Jana Joustra Davis	SVP	Sell	8,302	$85.02	$705,836.04	36,589
5/10/2017	Jane D Englebright	SVP	Sell	5,005	$85.31	$426,976.55	17,351
5/5/2017	Robert A Waterman	SVP	Sell	246,000	$83.12	$20,447,520.00	392,252
5/5/2017	Thomas F Frist Jr	Major Shareholder	Buy	361,205	$83.06	$30,001,687.30	167,000
4/17/2017	Michael S Cuffe	Insider	Sell	2,150	$85.00	$182,750.00	12,254
3/27/2017	Ravi S Chari	SVP	Sell	31,956	$90.00	$2,876,040.00	7,754
2/7/2017	John M Steele	SVP	Sell	31,535	$82.55	$2,603,214.25	44,308
2/3/2017	Charles J Hall	Insider	Sell	100,000	$83.79	$8,379,000.00	76,969
2/3/2017	Jana Joustra Davis	SVP	Sell	7,903	$82.49	$651,918.47	65,711
2/2/2017	Charles J Hall	Insider	Sell	100,000	$82.38	$8,238,000.00	92,519
1/17/2017	Michael S Cuffe	Insider	Sell	2,150	$80.00	$172,000.00	9,736
1/9/2017	Michael S. Cuffe	Insider	Sell	4,300	$78.00	$335,400.00
11/9/2016	A Bruce Moore Jr	Insider	Sell	167,967	$73.65	$12,370,769.55	207,682
11/8/2016	Sandra L Morgan	SVP	Sell	18,556	$76.84	$1,425,843.04	7,968
11/7/2016	Christopher F Wyatt	SVP	Sell	3,152	$79.00	$249,008.00	7,558
10/28/2016	Michael S. Cuffe	Insider	Sell	2,150	$79.41	$170,731.50
10/28/2016	P. Martin Paslick	SVP	Sell	36,004	$78.79	$2,836,755.16	35,894
5/24/2016	Alan R Yuspeh	SVP	Sell	15,000	$77.82	$1,167,300.00	37,228
5/24/2016	Michael S Cuffe	Insider	Sell	2,575	$76.20	$196,215.00	9,868
5/20/2016	Joseph N Steakley	SVP	Sell	16,327	$77.07	$1,258,321.89	27,496
5/10/2016	Henry R Kravis	Major Shareholder	Sell	9,360,958	$80.12	$749,999,954.96
5/9/2016	Juan Vallarino	SVP	Sell	13,501	$81.27	$1,097,226.27	74,537
5/6/2016	Charles J Hall	Insider	Sell	100,023	$80.99	$8,100,862.77	58,067
5/6/2016	Joseph N Steakley	SVP	Sell	60,004	$80.82	$4,849,523.28	37,492
5/5/2016	Jana Joustra Davis	SVP	Sell	11,970	$80.02	$957,839.40	116,115
5/4/2016	Charles O Holliday Jr	Director	Buy	4,000	$79.68	$318,720.00	8,000
5/4/2016	P. Martin Paslick	SVP	Sell	18,000	$79.46	$1,430,280.00	44,892
4/28/2016	John M Steele	SVP	Sell	40,004	$82.56	$3,302,730.24	28,238
4/28/2016	Jonathan B Perlin	CMO	Sell	30,000	$82.00	$2,460,000.00	15,632
4/25/2016	Michael S Cuffe	Insider	Sell	2,575	$80.73	$207,879.75	9,868
4/18/2016	John M Steele	SVP	Sell	19,464	$81.00	$1,576,584.00	30,198
4/14/2016	John M Steele	SVP	Sell	3,036	$81.00	$245,916.00	13,612
3/24/2016	Michael S Cuffe	Insider	Sell	2,575	$76.19	$196,189.25	9,868
3/23/2016	John M Steele	SVP	Sell	22,500	$78.00	$1,755,000.00	11,219
2/24/2016	Michael S Cuffe	Insider	Sell	2,575	$70.00	$180,250.00	8,425
2/19/2016	Jana Joustra Davis	SVP	Sell	36,159	$67.17	$2,428,800.03	109,683
2/17/2016	Jane D. Englebright	SVP	Sell	4,436	$67.08	$297,566.88	14,021
2/1/2016	David Gwin Anderson	SVP	Sell	35,013	$70.52	$2,469,116.76	94,364
1/29/2016	Victor L. Campbell	SVP	Sell	165,016	$68.86	$11,363,001.76	128,220
1/28/2016	Michael S. Cuffe	insider	Sell	5,150	$70.00	$360,500.00
12/1/2015	Michael S. Cuffe	insider	Sell	2,575	$70.00	$180,250.00	4,451
10/26/2015	Michael S. Cuffe	insider	Sell	2,575	$70.00	$180,250.00	4,451
9/24/2015	Michael S. Cuffe	insider	Sell	2,575	$83.42	$214,806.50	4,451
8/25/2015	Juan Vallarino	SVP	Sell	27,002	$85.76	$2,315,691.52	61,361
8/24/2015	Michael S. Cuffe	insider	Sell	2,575	$82.32	$211,974.00	4,355
8/17/2015	Donald W Stinnett	SVP	Sell	67,506	$91.25	$6,159,922.50
8/14/2015	Alan R Yuspeh	SVP	Sell	14,000	$91.24	$1,277,360.00
8/13/2015	Juan Vallarino	SVP	Sell	11,036	$90.89	$1,003,062.04
6/25/2015	Jonathan B Perlin	CMO	Sell	32,010	$87.31	$2,794,793.10
6/11/2015	R Milton Johnson	CEO	Sell	140,642	$83.89	$11,798,457.38
5/22/2015	Donald W Stinnett	SVP	Sell	22,502	$82.39	$1,853,939.78
5/20/2015	Jana Joustra Davis	SVP	Sell	3,302	$82.74	$273,207.48
5/19/2015	Jon M Foster	Insider	Sell	36,000	$81.00	$2,916,000.00
5/19/2015	Jonathan B Perlin	CMO	Sell	18,000	$83.00	$1,494,000.00
5/18/2015	A Bruce Moore Jr	Insider	Sell	100,000	$80.83	$8,083,000.00
5/18/2015	David Gwin Anderson	SVP	Sell	30,000	$80.67	$2,420,100.00
5/18/2015	Jonathan B Perlin	CMO	Sell	18,000	$81.00	$1,458,000.00
5/18/2015	R Milton Johnson	CEO	Sell	140,642	$79.89	$11,235,889.38
5/7/2015	Charles J Hall	Insider	Sell	252,026	$74.54	$18,786,018.04
4/15/2015	Samuel N Hazen	COO	Sell	180,000	$80.00	$14,400,000.00
2/23/2015	Charles J Hall	Insider	Sell	50,000	$70.10	$3,505,000.00
2/12/2015	Jane D Englebright	SVP	Sell	10,774	$69.06	$744,052.44
1/12/2015	Donald W Stinnett	SVP	Sell	2,521	$76.00	$191,596.00
12/23/2014	John M Steele	SVP	Sell	14,000	$75.00	$1,050,000.00
12/23/2014	Jonathan B Perlin	CMO	Sell	10,000	$75.00	$750,000.00
12/23/2014	Samuel N Hazen	Insider	Sell	180,051	$75.00	$13,503,825.00
11/3/2014	John M Steele	SVP	Sell	13,000	$72.00	$936,000.00
11/3/2014	Jonathan B Perlin	CMO	Sell	10,000	$72.00	$720,000.00
8/4/2014	Samuel N Hazen	Insider	Sell	19,374	$66.00	$1,278,684.00
7/30/2014	David Gwin Anderson	SVP	Sell	22,524	$66.53	$1,498,521.72
7/16/2014	Juan Vallarino	SVP	Sell	15,000	$60.00	$900,000.00
6/20/2014	Juan Vallarino	SVP	Sell	15,000	$57.50	$862,500.00
6/5/2014	Jonathan B Perlin	CMO	Sell	20,000	$55.00	$1,100,000.00
5/6/2014	Wayne Joseph Riley	Director	Sell	10,000	$52.00	$520,000.00	6,749
5/5/2014	David Gwin Anderson	SVP	Sell	42,007	$52.22	$2,193,605.54	94,713
5/2/2014	A Bruce Moore, Jr.	Insider	Sell	75,174	$52.53	$3,948,890.22	133,892
5/1/2014	Juan Vallarino	SVP	Sell	15,000	$52.50	$787,500.00	72,419
4/30/2014	John Rowe	Director	Buy	14,356	$52.24	$749,957.44	20,536
2/19/2014	Charles Hall	Insider	Sell	185,596	$49.92	$9,264,952.32	11,141
2/7/2014	Samuel Hazen	Insider	Sell	29,016	$48.00	$1,392,768.00	28,093
11/26/2013	Juan Vallarino	SVP	Sell	22,042	$45.00	$991,890.00	91,744
9/18/2013	Donald Stinnett	SVP	Sell	12,500	$42.00	$525,000.00	51,438
8/20/2013	John Steele	SVP	Sell	33,189	$38.63	$1,282,091.07	6,645
8/14/2013	Juan Vallarino	SVP	Sell	50,142	$39.49	$1,980,107.58	91,744
5/17/2013	Jon M Foster	Insider	Sell	15,955	$39.04	$622,883.20
8/8/2012	Of America Corp /De/ Bank	Major Shareholder	Sell	145,491	$26.91	$3,915,162.81

(Data available from 1/1/2013 forward)

HCA Healthcare (NYSE HCA) News Headlines

Source:

Date	Headline
	Exclusive: New estimated $75M-$82M mixed-use project with a hotel and more headed to Central Florida finance.yahoo.com - May 25 at 6:10 PM
	Cantor Fitzgerald Weighs in on HCA Healthcare Inc's FY2019 Earnings (HCA) www.americanbankingnews.com - May 23 at 7:45 AM
	At $103.86, Is It Time To Buy HCA Healthcare Inc (NYSE:HCA)? finance.yahoo.com - May 22 at 5:17 PM
	Report: HCA could buy 5 KC-area surgery centers www.bizjournals.com - May 22 at 8:08 AM
	Free Research Report as HCA Healthcare's Revenue Grew 8%; Adjusted EPS Surged 34% finance.yahoo.com - May 22 at 8:08 AM
	HCA Healthcare Inc (HCA) Insider Sells $1,198,080.00 in Stock www.americanbankingnews.com - May 21 at 7:18 PM
	Hospital Co. of America (HCA) Given Average Rating of "Hold" by Brokerages www.americanbankingnews.com - May 17 at 2:23 PM
	$11.31 Billion in Sales Expected for Hospital Co. of America (HCA) This Quarter www.americanbankingnews.com - May 16 at 2:36 AM
	TriStar announces more than $500 million in Middle Tennessee investments finance.yahoo.com - May 14 at 5:31 PM
	Brokerages Anticipate Hospital Co. of America (HCA) to Announce $2.15 EPS www.americanbankingnews.com - May 14 at 3:12 PM
	Good Works: Dining Out For Life raises $350K for Project Angel Heart www.bizjournals.com - May 11 at 8:02 AM
	Stock Performance Review on Community Health Systems and Three More Hospitals Industry Stocks finance.yahoo.com - May 10 at 8:04 AM
	Q2 2018 Earnings Estimate for Hospital Co. of America (HCA) Issued By Piper Jaffray www.americanbankingnews.com - May 9 at 8:45 AM
	A Look At The Fair Value Of HCA Healthcare Inc (NYSE:HCA) finance.yahoo.com - May 8 at 8:03 AM
	Factors of Influence in 2018, Key Indicators and Opportunity within HCA Healthcare, Apartment Investment and Management, KeyCorp, Essex Property Trust, HOSTESS BRANDS, and TripAdvisor — New Research Emphasizes Economic Growth finance.yahoo.com - May 7 at 8:07 AM
	"Fast Money" final trades: PYPL, HD and more finance.yahoo.com - May 4 at 8:06 AM
	Hospital operator HCA spends big to keep nurses on board finance.yahoo.com - May 4 at 8:06 AM
	Leerink Swann Analysts Lower Earnings Estimates for Hospital Co. of America (HCA) www.americanbankingnews.com - May 4 at 7:56 AM
	Hospital Co. of America to Post Q2 2018 Earnings of $2.17 Per Share, Oppenheimer Forecasts (HCA) www.americanbankingnews.com - May 4 at 7:56 AM
	Q2 2018 EPS Estimates for Hospital Co. of America Decreased by Analyst (HCA) www.americanbankingnews.com - May 4 at 7:56 AM
	Q3 2018 EPS Estimates for Hospital Co. of America Decreased by Jefferies Group (HCA) www.americanbankingnews.com - May 4 at 7:42 AM
	Equities Analysts Offer Predictions for Hospital Co. of America's Q4 2018 Earnings (HCA) www.americanbankingnews.com - May 3 at 9:24 AM
	FY2018 EPS Estimates for Hospital Co. of America Boosted by Analyst (HCA) www.americanbankingnews.com - May 3 at 9:04 AM
	Hospital Co. of America Forecasted to Post Q2 2018 Earnings of $2.14 Per Share (HCA) www.americanbankingnews.com - May 3 at 8:17 AM
	HCA Healthcare's Profits Jump finance.yahoo.com - May 2 at 5:48 PM
	Hospital Co. of America (HCA) Declares $0.35 Quarterly Dividend www.americanbankingnews.com - May 2 at 1:48 PM
	HCA Healthcare quarterly profit rises 73.6 percent www.reuters.com - May 2 at 8:07 AM
	Hospital operator HCA Healthcare's results beat estimates www.reuters.com - May 2 at 8:07 AM
	Edited Transcript of HCA earnings conference call or presentation 1-May-18 3:00pm GMT finance.yahoo.com - May 2 at 8:07 AM
	HCA Reports First Quarter 2018 Results finance.yahoo.com - May 1 at 5:28 PM
	HCA: 1Q Earnings Snapshot finance.yahoo.com - May 1 at 5:28 PM
	HCA Healthcare reports Q1 sales, profit beats finance.yahoo.com - May 1 at 5:28 PM
	HCA Healthcare quarterly profit rises 73.6 pct finance.yahoo.com - May 1 at 5:28 PM
	HCA Healthcare results beat on high-margin patient admissions finance.yahoo.com - May 1 at 5:28 PM
	HCA Healthcare (HCA) Beats on Q1 Earnings, Keeps Guidance finance.yahoo.com - May 1 at 5:28 PM
	HCA Healthcare (HCA) Q1 Earnings and Revenues Top Estimates finance.yahoo.com - May 1 at 5:28 PM
	Hospital Co. of America (HCA) Announces Earnings Results www.americanbankingnews.com - May 1 at 2:18 PM
	Hospital Co. of America (HCA) Releases FY18 Earnings Guidance www.americanbankingnews.com - May 1 at 9:26 AM
	Why I'm Long HCA Holdings seekingalpha.com - April 30 at 8:03 AM
	$11.27 Billion in Sales Expected for Hospital Co. of America (HCA) This Quarter www.americanbankingnews.com - April 29 at 5:04 AM
	Hospital Co. of America (HCA) Expected to Post Earnings of $2.07 Per Share www.americanbankingnews.com - April 27 at 3:30 AM
	Head-To-Head Comparison: Hospital Co. of America (HCA) versus Surgery Partners (SGRY) www.americanbankingnews.com - April 26 at 3:14 PM
	"Fast Money" final trades: T, TWTR and more finance.yahoo.com - April 26 at 8:03 AM
	Interested In HCA Healthcare Inc (NYSE:HCA)? Here’s How It Performed Recently finance.yahoo.com - April 26 at 8:03 AM
	After five-year effort, regulations on free-standing emergency rooms are becoming law finance.yahoo.com - April 25 at 5:40 PM
	Exclusive: SA hospital owner giving $27M in grants to expand care in South Texas finance.yahoo.com - April 25 at 5:40 PM
	Stock Traders Purchase High Volume of Hospital Co. of America Put Options (HCA) www.americanbankingnews.com - April 24 at 6:11 AM
	Hospital Co. of America (HCA) Scheduled to Post Earnings on Monday www.americanbankingnews.com - April 23 at 2:28 AM
	Hospital Co. of America (HCA) Given Consensus Rating of "Hold" by Brokerages www.americanbankingnews.com - April 22 at 1:36 PM
	Contrasting Hospital Co. of America (HCA) & Surgery Partners (SGRY) www.americanbankingnews.com - April 22 at 3:11 AM

HCA Healthcare (NYSE:HCA) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

HCA Healthcare (NYSE:HCA) Income Statement, Balance Sheet and Cash Flow Statement

HCA Healthcare (NYSE HCA) Stock Chart for Saturday, May, 26, 2018

Loading chart…

This page was last updated on 5/26/2018 by MarketBeat.com Staff